The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

IBM Watson and the American Diabetes Association (ADA) will collaborate to create better disease management tools for those affected by diabetes. The project, unveiled at the ADA’s 76 th ...

Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share ...

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

Diabetes costs US employers over $106B in lost productivity. Learn how data-driven support can improve employee health and ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

From educational sessions on diabetes management to exciting outdoor adventures, every moment at Camp He Ola Ke Keiki is crafted to inspire independence and foster self-confidence. The ADA’s ...

PharmaSens, a developer of innovative insulin patch pumps for people with diabetes, has announced the appointment of Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.